LPL Financial’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.45M | Buy |
135,546
+41,120
| +44% | +$1.68M | ﹤0.01% | 2425 |
|
|
2026
Q1 | $3.14M | Sell |
94,426
-2,107
| -2% | -$62.8K | ﹤0.01% | 3082 |
|
|
2025
Q4 | $2.88M | Sell |
96,533
-38,046
| -28% | -$1.24M | ﹤0.01% | 3052 |
|
|
2025
Q3 | $4.86M | Sell |
134,579
-30,524
| -18% | -$1.01M | ﹤0.01% | 2484 |
|
|
2025
Q2 | $5.94M | Sell |
165,103
-19,960
| -11% | -$743K | ﹤0.01% | 2175 |
|
|
2025
Q1 | $7.3M | Buy |
185,063
+1
| +0% | +$34 | ﹤0.01% | 1839 |
|
|
2024
Q4 | $5.57M | Buy |
185,062
+70,740
| +62% | +$2.03M | ﹤0.01% | 1994 |
|
|
2024
Q3 | $2.67M | Sell |
114,322
-18,958
| -14% | -$414K | ﹤0.01% | 2458 |
|
|
2024
Q2 | $2.37M | Buy |
133,280
+18,778
| +16% | +$300K | ﹤0.01% | 2451 |
|
|
2024
Q1 | $1.74M | Buy |
114,502
+21,934
| +24% | +$349K | ﹤0.01% | 2651 |
|
|
2023
Q4 | $1.58M | Buy |
92,568
+1,180
| +1% | +$13.7K | ﹤0.01% | 2638 |
|
|
2023
Q3 | $764K | Buy |
91,388
+24,230
| +36% | +$338K | ﹤0.01% | 3135 |
|
|
2023
Q2 | $1.67M | Buy |
67,158
+17,010
| +34% | +$439K | ﹤0.01% | 2410 |
|
|
2023
Q1 | $754K | Buy |
50,148
+11,293
| +29% | +$172K | ﹤0.01% | 2985 |
|
|
2022
Q4 | $460K | Buy |
38,855
+11,480
| +42% | +$83.3K | ﹤0.01% | 3328 |
|
|
2022
Q3 | $162K | Sell |
27,375
-1,265
| -4% | -$8.3K | ﹤0.01% | 4009 |
|
|
2022
Q2 | $122K | Sell |
28,640
-1,286
| -4% | -$8.03K | ﹤0.01% | 4086 |
|
|
2022
Q1 | $285K | Buy |
29,926
+2,632
| +10% | +$30.5K | ﹤0.01% | 3598 |
|
|
2021
Q4 | $519K | Buy |
27,294
+461
| +2% | +$12K | ﹤0.01% | 3250 |
|
|
2021
Q3 | $893K | Buy |
26,833
+7,476
| +39% | +$231K | ﹤0.01% | 2705 |
|
|
2021
Q2 | $751K | Buy |
19,357
+7,909
| +69% | +$311K | ﹤0.01% | 2808 |
|
|
2021
Q1 | $552K | Sell |
11,448
-8,936
| -44% | -$429K | ﹤0.01% | 2941 |
|
|
2020
Q4 | $1.06M | Buy |
20,384
+5,999
| +42% | +$203K | ﹤0.01% | 2135 |
|
|
2020
Q3 | $385K | Buy |
14,385
+81
| +0.6% | +$1.86K | ﹤0.01% | 2697 |
|
|
2020
Q2 | $279K | Buy |
14,304
+985
| +7% | +$15.9K | ﹤0.01% | 2889 |
|
|
2020
Q1 | $131K | Sell |
13,319
-677
| -5% | -$8.55K | ﹤0.01% | 2935 |
|
|
2019
Q4 | $155K | Buy |
13,996
+2,233
| +19% | +$17K | ﹤0.01% | 3159 |
|
|
2019
Q3 | $66K | Sell |
11,763
-175
| -1% | -$1.22K | ﹤0.01% | 3190 |
|
|
2019
Q2 | $103K | Buy |
11,938
+309
| +3% | +$2.34K | ﹤0.01% | 3150 |
|
|
2019
Q1 | $93K | Sell |
11,629
-283
| -2% | -$1.53K | ﹤0.01% | 3077 |
|
|
2018
Q4 | $49K | Buy |
+11,912
| New | +$59.2K | ﹤0.01% | 3006 |
|
Other funds holding TGTX
SCM
CAM
LPL Financial's TGTX Position: Q2 2026 in Review
LPL Financial increased its TG Therapeutics (TGTX) stake by 44% in Q2 2026, buying an estimated $1.68M and bringing the position to 135,546 shares worth $7.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2425.
LPL Financial first reported a position in TGTX in Q4 2018 and has held it in 31 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- LPL Financial held 135,546 shares of TG Therapeutics worth $7.45M as of Q2 2026.
- LPL Financial bought 41,120 TG Therapeutics shares in Q2 2026, an estimated $1.68M.
- TG Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2425 holding.
- LPL Financial first reported a position in TG Therapeutics in Q4 2018 and has held it in 31 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.